We've found
6,735
archived clinical trials in
Psoriasis
We've found
6,735
archived clinical trials in
Psoriasis
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Updated: 8/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Status: Enrolling
Updated: 8/10/2015
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Updated: 8/10/2015
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials